Hansen Medical, Inc., a global leader in intravascular robotics, today announced it will showcase its Magellan™ Robotic System at the 35th Annual Charing Cross International Symposium from April 6-9 in London. The Company will be exhibiting the Magellan Robotic System at Booth 628.
In addition, Professor Nick Cheshire, MD of St. Mary's Hospital, part of the Imperial College Healthcare NHS Trust in London, and Barry Katzen, MD, founder and Medical Director of the Baptist Cardiac & Vascular Institute (Baptist Hospital of Miami), will participate in a panel discussion titled, "Great Debate: Influence of Robotics and Simulators," during the "Carotid Challenges" session at 10:00 am on Tuesday, April 9.
Hansen Medical will also be co-sponsoring a symposium with Philips Healthcare from 12:30 pm-3:30 pm on Monday, April 8 in the Green Learning Center, titled "Advanced Imaging in the Hybrid Operating Room." This symposium will feature Dr. Katzen who will discuss his clinical experiences with the Magellan System in a variety of interventional procedures.
Lastly, on Sunday, April 7 at 4:45 pm Professor Jean-Pierre Becquemin, MD of Creteil, France will present on his experiences with the Magellan System in a presentation titled, "Early Experiences with Intravascular Robotics."
"We are pleased that our Magellan Robotic System will be highlighted at Charing Cross, Europe's longest running and leading vascular symposium," said Bruce Barclay, President and CEO of Hansen Medical. "The presentations featuring our technology will provide additional opportunities for clinicians to better understand the significant clinical and economic benefits, and real world medical utility, provided by the Magellan System. We are also excited to be co-hosting a symposium with our partner Philips for the second consecutive year. Since commencing the initial U.S. launch of the Magellan System last June, we have generated a large and growing pipeline of clinical interest in our robotic technology, and we look forward to further building on this momentum at Charing Cross."
"At St. Mary's, we have performed a breadth of complex endovascular procedures with the Magellan Robotic System in the past year," said Professor Cheshire. "Charing Cross, being the premier European endovascular event, affords us the opportunity to discuss the clinical benefits we're seeing through the implementation of intravascular robotics."
About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is based upon the flexible robotic technology incorporated in the Sensei-X® Robotic Catheter System currently sold in the U.S. and Europe, which has been used in excess of 10,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:
- Provides solid catheter stability for placement of therapeutic devices.
- Is designed to enable predictable procedure times and increased case throughput.
- Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires.
- Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy.
- Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today.
- Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.